SCHEMBL10185581

SCHEMBL10185581

O=C1C(N(C(=O)Cn2cncn2)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 6/20 0.49
▸ RORC P51449 1/20 0.36
▸ OPRM1 P35372 2/20 0.35
▸ OPRK1 P41145 2/20 0.35
▸ OPRL1 P41146 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ HDAC5 Q9UQL6 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CCKAR P32238 2/20 0.33
▸ CCKBR P32239 2/20 0.33
▸ AGTR2 P50052 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10185644 0.88 IDH1 (0.48) IDH1OPRM1OPRK1OPRL1KMT2A
SCHEMBL10183680 0.85 IDH1 (0.39) IDH1OPRM1OPRK1OPRL1MEN1
SCHEMBL10183615 0.85 RORC (0.36) IDH1RORCOPRM1OPRK1OPRL1
SCHEMBL10185921 0.85 IDH1 (0.38) IDH1RORCOPRM1OPRK1OPRL1
SCHEMBL10183299 0.84 OPRM1 (0.40) IDH1OPRM1OPRK1OPRL1CCKAR
SCHEMBL10183337 0.83 OPRM1 (0.39) IDH1OPRM1OPRK1OPRL1MEN1
SCHEMBL10183319 0.83 MEN1 (0.43) IDH1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10184102 0.83 IDH1 (0.37) IDH1OPRM1OPRK1OPRL1MEN1
SCHEMBL10183782 0.83 OPRM1 (0.40) IDH1OPRM1OPRK1OPRL1CCKAR
SCHEMBL10183290 0.82 IDH1 (0.50) IDH1HDAC1HDAC8HDAC6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback